About Olive Therapeutics Private Limited
Data last updated:
Olive Therapeutics Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 1993.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U36100MH1993PTC071372.
The company had an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It was formerly known as Shaalkaya Developers Private Limited and Savita Pharmaceuticals Private Limited.
Its last annual general meeting (AGM) was held on 28 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at B – 203 Godrej Coliseum Somaiyahospital Rd Off Eastern Sion(E), Mumbai, Maharashtra, India.
As per MCA filings, the company has satisfied charges of ₹2.77 Cr on record.
The last known website on record is myolivehealthcare.com.
Company details
Name history
Olive Therapeutics has undergone 2 name changes throughout its history. The company was previously known as Shaalkaya Developers Private Limited, and Savita Pharmaceuticals Private Limited. The current legal name is Olive Therapeutics Private Limited.
| Company Name | Status |
|---|---|
| Olive Therapeutics Private Limited | Current |
| Shaalkaya Developers Private Limited | Previous |
| Savita Pharmaceuticals Private Limited | Previous |
CIN history
Olive Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U36100MH1993PTC071372, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U36100MH1993PTC071372 | Current |
| U74900MH1993PTC071372 | Previous |
| U24230MH1993PTC071372 | Previous |
Contact details
Olive Therapeutics Private Limited's registered office is in Mumbai, Maharashtra. Its website is myolivehealthcare.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressB – 203 Godrej Coliseum Somaiyahospital Rd Off Eastern Sion(E), Mumbai, Maharashtra, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Olive Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Olive Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Olive Therapeutics Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Olive Therapeutics Private Limited, buy the company report.
Board of directors of Olive Therapeutics Private Limited
Olive Therapeutics has 5 former directors on record and no current directors listed.
Shareholding
The shareholding of Olive Therapeutics Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Olive Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 1997 | 90163647 | Bank of Baroda | ₹75 Lakh | Satisfied | |
| 20 Dec 1997 | 90163644 | Bank of Baroda | ₹1.16 Cr | Satisfied | |
| 17 Oct 1996 | 90163445 | Bank of Baroda | ₹10.53 Lakh | Satisfied | |
| 31 Dec 1993 | 90162838 | Bank of Baroda | ₹75 Lakh | Satisfied |
To see the full charge records of Olive Therapeutics Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Olive Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Olive Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Olive Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Olive Therapeutics Private Limited has 5 board changes on record since 2009: 0 appointments and 5 cessations. The latest: Hardik Kamlesh Shah ceased to be Additional Director on 14 Jun 2021.
7 earlier events are in the company report.
News
Frequently asked questions
Olive Therapeutics has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Olive Therapeutics was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 29 March 1993 and is registered under CIN U36100MH1993PTC071372. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Olive Therapeutics is U36100MH1993PTC071372. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Olive Therapeutics was incorporated on 29 March 1993. It is registered with the Registrar of Companies, Mumbai.
Olive Therapeutics can be reached through the website myolivehealthcare.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Olive Therapeutics is at B – 203 Godrej Coliseum Somaiyahospital Rd Off Eastern SionE, Mumbai, Maharashtra, India.
The latest financial statements of Olive Therapeutics on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 28 September 2020. Year-wise statements from 2015 are in the company report.
Olive Therapeutics operated in the pharma industry, in the drug formulation and development segment.
Hardik Kamlesh Shah ceased to be Additional Director on 14 Jun 2021. Jigar Kamlesh Shah ceased to be Additional Director on 14 Jun 2021. Kamlesh Shah ceased to be Director on 07 May 2021. Olive Therapeutics has 5 board changes on record in total.
Olive Therapeutics has no open charges and satisfied charges of ₹2.77 Cr as per latest MCA filings.